伴有肾癌骨转移患者，推荐应用双膦酸盐药物，以减少骨相关事件的发生。
Bisphosphonates is recommended for patients with bone metastases which can reduce the incidence of bone-related events.
为进行这一试验，研究者们从23个国家招募了近2,000名没有服用过双膦酸盐类药物的患者。
For the study, researchers recruited about 2,000 patients from 23 countries who were not taking oral bisphosphonates.
目前双膦酸盐类药物治疗骨转移的主要目的是减少骨相关事件、减轻疼痛和提高生活质量。
The current aims of bi- sphosphonates for metastatic bone disease are to prevent skeletal-related events, reduce bone pain, and improve quality of life.
应用推荐